1	Hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	0-6	506_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	7-9	506_QUEST_clinical_caseMIR	SENT1	-	-
3	35	35		-	-	10-12	506_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	13-17	506_QUEST_clinical_caseMIR	SENT1	-	-
5	que	que	PR0CN000	-	-	18-21	506_QUEST_clinical_caseMIR	SENT1	-	-
6	acude	acudir	VMIP3S0	-	-	22-27	506_QUEST_clinical_caseMIR	SENT1	-	-
7	a	a	SPS00	-	-	28-29	506_QUEST_clinical_caseMIR	SENT1	-	-
8	urgencias	urgencia	NCFP000	C0439609	calificador	30-39	506_QUEST_clinical_caseMIR	SENT1	-	-
9	por	por	SPS00	C0678226	atributo	40-43	506_QUEST_clinical_caseMIR	SENT1	-	-
10	cuadro	cuadro	NCMS000	-	-	44-50	506_QUEST_clinical_caseMIR	SENT1	-	-
11	de	de	SPS00	C0332285	atributo	51-53	506_QUEST_clinical_caseMIR	SENT1	-	-
12	48	48	Z	C0439586_1	calificador_1	54-56	506_QUEST_clinical_caseMIR	SENT1	-	-
13	horas	hora	NCFP000	C0439586_2	calificador_2	57-62	506_QUEST_clinical_caseMIR	SENT1	-	-
14	de	de	SPS00	C0332285	atributo	63-65	506_QUEST_clinical_caseMIR	SENT1	-	-
15	evolución	evolución	NCFS000	-	-	66-75	506_QUEST_clinical_caseMIR	SENT1	-	-
16	de	de	SPS00	C0332285	atributo	76-78	506_QUEST_clinical_caseMIR	SENT1	-	-
17	fiebre	fiebre	NCFS000	C0015967	hallazgo	79-85	506_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
18	de	de	SPS00	C0332285	atributo	86-88	506_QUEST_clinical_caseMIR	SENT1	-	-
19	39ºC	39ºC		-	-	89-93	506_QUEST_clinical_caseMIR	SENT1	-	-
20	,	,	Fc	-	-	93-94	506_QUEST_clinical_caseMIR	SENT1	-	-
21	tiritona	tiritona	NCFS000	-	-	95-103	506_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
22	,	,	Fc	-	-	103-104	506_QUEST_clinical_caseMIR	SENT1	-	-
23	mal	mal	RG	C0205169	calificador	105-108	506_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
24	estado	estado	NCMS000	C0449438#C1301808	atributo#medio_ambiente	109-115	506_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
25	general	general	AQ0CS0	C0205246	calificador	116-123	506_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
26	,	,	Fc	-	-	123-124	506_QUEST_clinical_caseMIR	SENT1	-	-
27	polaquiuria	polaquiuria	NC00SC0	C0042023_1	hallazgo_1	125-136	506_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
28	,	,	Fc	-	-	136-137	506_QUEST_clinical_caseMIR	SENT1	-	-
29	disuria	disuria	NCFS000	C0013428	hallazgo	138-145	506_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
30	,	,	Fc	-	-	145-146	506_QUEST_clinical_caseMIR	SENT1	-	-
31	tenesmo	tenesmo	NCMS000	C0423735_1	hallazgo_1	147-154	506_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
32	vesical	vesical	AQ0CS0	C0423735_2	hallazgo_2	155-162	506_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
33	y	y	CC	C1706368	calificador	163-164	506_QUEST_clinical_caseMIR	SENT1	-	-
34	dolor	dolor	NCMS000	C0585134_1	hallazgo_1	165-170	506_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
35	perianal	perianal	NC00SC0	C0585134_2	hallazgo_2	171-179	506_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
36	.	.	Fp	-	-	179-180	506_QUEST_clinical_caseMIR	SENT1	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	181-183	506_QUEST_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	184-186	506_QUEST_clinical_caseMIR	SENT2	-	-
3	analítica	analítica	NCFS000	-	-	187-196	506_QUEST_clinical_caseMIR	SENT2	-	-
4	presenta	presentar	VMIP3S0	-	-	197-205	506_QUEST_clinical_caseMIR	SENT2	-	-
5	valores	valor	NCMP000	C0475208	calificador	206-213	506_QUEST_clinical_caseMIR	SENT2	-	-
6	de	de	SPS00	C0332285	atributo	214-216	506_QUEST_clinical_caseMIR	SENT2	-	-
7	creatinina	creatinina	NC00SC0	C0010294	sustancia	217-227	506_QUEST_clinical_caseMIR	SENT2	-	-
8	de	de	SPS00	C0332285	atributo	228-230	506_QUEST_clinical_caseMIR	SENT2	-	-
9	0,9	0.9	Z	-	-	231-234	506_QUEST_clinical_caseMIR	SENT2	-	-
10	mg	mg	NCMN000	-	-	235-237	506_QUEST_clinical_caseMIR	SENT2	-	-
11	/	/	Fh	-	-	237-238	506_QUEST_clinical_caseMIR	SENT2	-	-
12	dL	decilitro	NCMN000	C0439241	calificador	238-240	506_QUEST_clinical_caseMIR	SENT2	-	-
13	,	,	Fc	-	-	240-241	506_QUEST_clinical_caseMIR	SENT2	-	-
14	procalcitonina	procalcitonina	NC00SC0	C0072027	sustancia	242-256	506_QUEST_clinical_caseMIR	SENT2	-	-
15	de	de	SPS00	C0332285	atributo	257-259	506_QUEST_clinical_caseMIR	SENT2	-	-
16	1,5	1,5		-	-	260-263	506_QUEST_clinical_caseMIR	SENT2	-	-
17	ng	nasogástrico	NC00YL0	-	-	264-266	506_QUEST_clinical_caseMIR	SENT2	-	-
18	/	/	Fh	-	-	266-267	506_QUEST_clinical_caseMIR	SENT2	-	-
19	mL	mililitro	NCMN000	C0439242	calificador	267-269	506_QUEST_clinical_caseMIR	SENT2	-	-
20	,	,	Fc	-	-	269-270	506_QUEST_clinical_caseMIR	SENT2	-	-
21	leucocitos	leucocito	NCMP000	C0023516	célula	271-281	506_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
22	de	de	SPS00	C0332285	atributo	282-284	506_QUEST_clinical_caseMIR	SENT2	-	-
23	20.000/μL	20.000/μL		-	-	285-294	506_QUEST_clinical_caseMIR	SENT2	-	-
24	y	y	CC	C1706368	calificador	295-296	506_QUEST_clinical_caseMIR	SENT2	-	-
25	PSA	prostate-specific_antigen_(antígeno_prostático_específico)	NC00YL0	-	-	297-300	506_QUEST_clinical_caseMIR	SENT2	-	-
26	de	de	SPS00	C0332285	atributo	301-303	506_QUEST_clinical_caseMIR	SENT2	-	-
27	45	45		-	-	304-306	506_QUEST_clinical_caseMIR	SENT2	-	-
28	ng	nasogástrico	NC00YL0	-	-	307-309	506_QUEST_clinical_caseMIR	SENT2	-	-
29	/	/	Fh	-	-	309-310	506_QUEST_clinical_caseMIR	SENT2	-	-
30	mL	mililitro	NCMN000	C0439242	calificador	310-312	506_QUEST_clinical_caseMIR	SENT2	-	-
31	.	.	Fp	-	-	312-313	506_QUEST_clinical_caseMIR	SENT2	-	-

1	Cuál	cuál	PT0CS000	-	-	314-318	506_QUEST_clinical_caseMIR	SENT3	-	-
2	es	ser	VSIP3S0	-	-	319-321	506_QUEST_clinical_caseMIR	SENT3	-	-
3	la	el	DA0FS0	-	-	322-324	506_QUEST_clinical_caseMIR	SENT3	-	-
4	actitud	actitud	NCFS000	C0004271	entidad_observable	325-332	506_QUEST_clinical_caseMIR	SENT3	-	-
5	a	a	SPS00	-	-	333-334	506_QUEST_clinical_caseMIR	SENT3	-	-
6	seguir	seguir	VMN0000	-	-	335-341	506_QUEST_clinical_caseMIR	SENT3	-	-
7	en	en	SPS00	C1720294#C0332285	calificador#atributo	342-344	506_QUEST_clinical_caseMIR	SENT3	-	-
8	este	este	DD0MS0	-	-	345-349	506_QUEST_clinical_caseMIR	SENT3	-	-
9	paciente	paciente	NCCS000	C0030705	persona	350-358	506_QUEST_clinical_caseMIR	SENT3	-	-
10	.	.	Fp	-	-	358-359	506_QUEST_clinical_caseMIR	SENT3	-	-

